Regulatory circuitry governing fungal development, drug resistance, and disease.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMC 3122626)

Published in Microbiol Mol Biol Rev on June 01, 2011

Authors

Rebecca S Shapiro1, Nicole Robbins, Leah E Cowen

Author Affiliations

1: Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S1A8, Canada.

Articles citing this

Growth of Candida albicans hyphae. Nat Rev Microbiol (2011) 3.02

Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog (2011) 1.53

Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med (2014) 1.31

Systems-level antimicrobial drug and drug synergy discovery. Nat Chem Biol (2013) 1.19

Activation and alliance of regulatory pathways in C. albicans during mammalian infection. PLoS Biol (2015) 1.14

Mechanisms of Candida biofilm drug resistance. Future Microbiol (2013) 1.13

Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. PLoS Pathog (2012) 1.10

A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLoS Genet (2012) 1.05

Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat Commun (2015) 1.02

Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides. PLoS Pathog (2013) 1.02

Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol (2012) 0.99

Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation. Microbes Infect (2012) 0.99

Candida albicans white and opaque cells undergo distinct programs of filamentous growth. PLoS Pathog (2013) 0.98

Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. PLoS Genet (2013) 0.97

Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance. Front Microbiol (2013) 0.97

Roles of Ras1 membrane localization during Candida albicans hyphal growth and farnesol response. Eukaryot Cell (2011) 0.97

A versatile overexpression strategy in the pathogenic yeast Candida albicans: identification of regulators of morphogenesis and fitness. PLoS One (2012) 0.95

Cdc28 provides a molecular link between Hsp90, morphogenesis, and cell cycle progression in Candida albicans. Mol Biol Cell (2011) 0.90

Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance. Cell Rep (2012) 0.90

The effect of biomaterials and antifungals on biofilm formation by Candida species: a review. Eur J Clin Microbiol Infect Dis (2012) 0.89

Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs. J Biol Chem (2015) 0.89

The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance. PLoS One (2012) 0.89

Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis. Antimicrob Agents Chemother (2012) 0.89

Sphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance. Antimicrob Agents Chemother (2014) 0.88

Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans. Mol Microbiol (2012) 0.87

Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans. PLoS One (2012) 0.87

Candida albicans flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity. Antimicrob Agents Chemother (2013) 0.87

In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms. Antimicrob Agents Chemother (2013) 0.86

Milbemycins: more than efflux inhibitors for fungal pathogens. Antimicrob Agents Chemother (2012) 0.86

Antifungal drug discovery: the process and outcomes. Future Microbiol (2014) 0.86

Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals. Antimicrob Agents Chemother (2013) 0.86

Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole. BMC Microbiol (2014) 0.85

Molecular characterization of the putative transcription factor SebA involved in virulence in Aspergillus fumigatus. Eukaryot Cell (2012) 0.83

A novel function for Hog1 stress-activated protein kinase in controlling white-opaque switching and mating in Candida albicans. Eukaryot Cell (2014) 0.83

Susceptibility of multispecies biofilm to photodynamic therapy using Photodithazine®. Lasers Med Sci (2013) 0.82

Sorbic acid stress activates the Candida glabrata high osmolarity glycerol MAP kinase pathway. Front Microbiol (2013) 0.82

Uncovering cellular circuitry controlling temperature-dependent fungal morphogenesis. Virulence (2012) 0.82

H3K4 methyltransferase Set1 is involved in maintenance of ergosterol homeostasis and resistance to Brefeldin A. Proc Natl Acad Sci U S A (2013) 0.82

A comprehensive functional portrait of two heat shock factor-type transcriptional regulators involved in Candida albicans morphogenesis and virulence. PLoS Pathog (2013) 0.82

Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol (2016) 0.81

An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens. Cell Rep (2015) 0.81

Candida albicans Biofilm Development and Its Genetic Control. Microbiol Spectr (2015) 0.81

Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation. PLoS Pathog (2015) 0.80

Antimicrobial-induced DNA damage and genomic instability in microbial pathogens. PLoS Pathog (2015) 0.80

Combinatorial strategies for combating invasive fungal infections. Virulence (2016) 0.80

Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability. Lasers Med Sci (2013) 0.80

Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress. Biomed Res Int (2015) 0.79

Regulatory circuitry governing morphogenesis in Saccharomyces cerevisiae and Candida albicans. Cell Cycle (2012) 0.79

Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stress. Antimicrob Agents Chemother (2015) 0.79

Gymnemic acids inhibit hyphal growth and virulence in Candida albicans. PLoS One (2013) 0.79

Signaling through Lrg1, Rho1 and Pkc1 Governs Candida albicans Morphogenesis in Response to Diverse Cues. PLoS Genet (2016) 0.79

Cell cycle-independent phospho-regulation of Fkh2 during hyphal growth regulates Candida albicans pathogenesis. PLoS Pathog (2015) 0.78

Ser or Leu: structural snapshots of mistranslation in Candida albicans. Front Mol Biosci (2014) 0.78

The zinc cluster protein Sut1 contributes to filamentation in Saccharomyces cerevisiae. Eukaryot Cell (2012) 0.78

Mapping the Hsp90 Genetic Network Reveals Ergosterol Biosynthesis and Phosphatidylinositol-4-Kinase Signaling as Core Circuitry Governing Cellular Stress. PLoS Genet (2016) 0.78

Alarmin(g) the innate immune system to invasive fungal infections. Curr Opin Microbiol (2016) 0.78

Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase. BMC Microbiol (2014) 0.77

Dual action antifungal small molecule modulates multidrug efflux and TOR signaling. Nat Chem Biol (2016) 0.77

Hsp21 potentiates antifungal drug tolerance in Candida albicans. PLoS One (2013) 0.77

Staurosporine Induces Filamentation in the Human Fungal Pathogen Candida albicans via Signaling through Cyr1 and Protein Kinase A. mSphere (2017) 0.76

A cytoplasmic new catalytic subunit of calcineurin in Trypanosoma cruzi and its molecular and functional characterization. PLoS Negl Trop Dis (2014) 0.76

Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29. Antimicrob Agents Chemother (2016) 0.76

New Insights Regarding Yeast Survival following Exposure to Liposomal Amphotericin B. Antimicrob Agents Chemother (2015) 0.76

De-repression of CSP-1 activates adaptive responses to antifungal azoles. Sci Rep (2016) 0.76

The transcriptional repressor TupA in Aspergillus niger is involved in controlling gene expression related to cell wall biosynthesis, development, and nitrogen source availability. PLoS One (2013) 0.76

Coordination of Candida albicans Invasion and Infection Functions by Phosphoglycerol Phosphatase Rhr2. Pathogens (2015) 0.76

Metal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis. PLoS Genet (2016) 0.76

Suppression of sensitivity to drugs and antibiotics by high external cation concentrations in fission yeast. PLoS One (2015) 0.76

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study. BMC Infect Dis (2015) 0.76

Genomic and functional analyses unveil the response to hyphal wall stress in Candida albicans cells lacking β(1,3)-glucan remodeling. BMC Genomics (2016) 0.75

Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity. Front Microbiol (2017) 0.75

Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host. World J Biol Chem (2017) 0.75

Heat Shock Protein 90 (Hsp90) as a Molecular Target for the Development of Novel Drugs Against the Dermatophyte Trichophyton rubrum. Front Microbiol (2015) 0.75

Antimicrobial Compounds Produced by Vaginal Lactobacillus crispatus Are Able to Strongly Inhibit Candida albicans Growth, Hyphal Formation and Regulate Virulence-related Gene Expressions. Front Microbiol (2017) 0.75

Decrease in Ribosomal RNA in Candida albicans Induced by Serum Exposure. PLoS One (2015) 0.75

The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn. Virulence (2016) 0.75

Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction. PLoS One (2017) 0.75

Role of Arf GTPases in fungal morphogenesis and virulence. PLoS Pathog (2017) 0.75

Regulation of Sterol Biosynthesis in the Human Fungal Pathogen Aspergillus fumigatus: Opportunities for Therapeutic Development. Front Microbiol (2017) 0.75

Hbr1 Activates and Represses Hyphal Growth in Candida albicans and Regulates Fungal Morphogenesis under Embedded Conditions. PLoS One (2015) 0.75

The Monoterpene Carvacrol Generates Endoplasmic Reticulum Stress in the Pathogenic Fungus Candida albicans. Antimicrob Agents Chemother (2015) 0.75

Potency of Massoia Bark in Combating Immunosuppressed-related Infection. Pharmacogn Mag (2016) 0.75

Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling. Antimicrob Agents Chemother (2017) 0.75

The Candida albicans HIR histone chaperone regulates the yeast-to-hyphae transition by controlling the sensitivity to morphogenesis signals. Sci Rep (2017) 0.75

Adaptive Mistranslation Accelerates the Evolution of Fluconazole Resistance and Induces Major Genomic and Gene Expression Alterations in Candida albicans. mSphere (2017) 0.75

Novel Cell-Killing Mechanisms of Hydroxyurea and the Implication Towards Combination Therapy for the Treatment of Fungal Infections. Antimicrob Agents Chemother (2017) 0.75

Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis Iran Biomed J (2017) 0.75

The interaction of aurein 2.5 with fungal membranes. Eur Biophys J (2014) 0.75

Articles cited by this

(truncated to the top 100)

TOR signaling in growth and metabolism. Cell (2006) 35.29

Status and trends of amphibian declines and extinctions worldwide. Science (2004) 18.40

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS (2009) 16.37

Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66

Nonfilamentous C. albicans mutants are avirulent. Cell (1997) 13.83

Hsp90 as a capacitor for morphological evolution. Nature (1998) 13.60

Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90

Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and Central America. Proc Natl Acad Sci U S A (1998) 11.62

An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53

TOR, a central controller of cell growth. Cell (2000) 10.41

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev (1998) 9.76

Invasive aspergillosis. Clin Infect Dis (1998) 9.72

Reconstructing the early evolution of Fungi using a six-gene phylogeny. Nature (2006) 8.94

Hsp90 as a capacitor of phenotypic variation. Nature (2002) 8.90

Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science (1994) 8.59

Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature (2005) 8.55

Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem (2007) 7.49

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother (1995) 7.44

HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol (2010) 7.16

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis (2002) 6.99

Emerging infectious disease and the loss of biodiversity in a Neotropical amphibian community. Proc Natl Acad Sci U S A (2006) 6.94

The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol (2008) 6.90

Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science (1997) 6.60

Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis (2001) 6.32

Echinocandin antifungal drugs. Lancet (2003) 5.92

Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature (2009) 5.90

Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem (2006) 5.82

Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol (1984) 5.74

Molecular evidence for the early colonization of land by fungi and plants. Science (2001) 5.49

Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev (2005) 5.46

White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell (2002) 5.36

Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun (1992) 5.27

Fungal secondary metabolism - from biochemistry to genomics. Nat Rev Microbiol (2005) 5.27

Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology (1997) 5.22

Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host. Science (2000) 5.22

Candida biofilms and their role in infection. Trends Microbiol (2003) 5.13

Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature (2005) 5.11

Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science (2005) 5.04

Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol (2005) 4.97

Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell (2005) 4.95

Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother (1998) 4.93

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother (2005) 4.89

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother (2001) 4.89

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother (1997) 4.87

Induction of mating in Candida albicans by construction of MTLa and MTLalpha strains. Science (2000) 4.84

Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J (1997) 4.82

Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (1997) 4.75

Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell (2003) 4.71

Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol (2001) 4.63

Resistance to echinocandin-class antifungal drugs. Drug Resist Updat (2007) 4.63

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother (2002) 4.52

A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica). J Bacteriol (1950) 4.48

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis (2006) 4.29

Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev (1997) 4.28

Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother (1996) 4.24

Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J (2005) 4.18

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (1997) 4.14

Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science (1999) 4.14

Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science (2006) 4.09

The damage-response framework of microbial pathogenesis. Nat Rev Microbiol (2003) 4.07

Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev (2003) 4.07

Epidemiology of invasive mycoses in North America. Crit Rev Microbiol (2010) 4.06

Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2001) 4.05

Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science (1999) 4.00

Treatment of invasive aspergillosis with itraconazole. Am J Med (1989) 3.87

Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol (2002) 3.87

The distinct morphogenic states of Candida albicans. Trends Microbiol (2004) 3.86

Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet (1995) 3.85

Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-beta-glucan synthase. Science (1996) 3.85

Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J (1997) 3.67

Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat Genet (2010) 3.65

Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc Natl Acad Sci U S A (1996) 3.65

Candida biofilms: an update. Eukaryot Cell (2005) 3.58

Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog (2006) 3.58

Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol (2002) 3.55

Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol (1978) 3.55

A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother (2007) 3.54

Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci U S A (1996) 3.50

NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J (2001) 3.48

Candida Albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet (2002) 3.46

RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol (2000) 3.45

Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. Genes Dev (1997) 3.40

Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A (2001) 3.37

Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol Biol Cell (2002) 3.36

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis. J Antimicrob Chemother (2006) 3.27

A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe (2010) 3.27

Genome-wide analysis of gene expression regulated by the calcineurin/Crz1p signaling pathway in Saccharomyces cerevisiae. J Biol Chem (2002) 3.26

Sexual reproduction between partners of the same mating type in Cryptococcus neoformans. Nature (2005) 3.22

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (1999) 3.19

PHR1, a pH-regulated gene of Candida albicans, is required for morphogenesis. Mol Cell Biol (1995) 3.18

Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother (2002) 3.18

A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (2003) 3.17

Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol (2003) 3.12

Mating-type locus of Cryptococcus neoformans: a step in the evolution of sex chromosomes. Eukaryot Cell (2002) 3.12

Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol (2001) 3.11

Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev (2009) 3.10

Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol (1999) 3.09

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect Immun (1996) 3.08

Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol (1999) 3.06

Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother (1995) 3.06

Articles by these authors

Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol (2009) 2.50

Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet (2009) 2.07

Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog (2009) 1.76

Global gene deletion analysis exploring yeast filamentous growth. Science (2012) 1.67

Pho85, Pcl1, and Hms1 signaling governs Candida albicans morphogenesis induced by high temperature or Hsp90 compromise. Curr Biol (2012) 1.65

PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog (2010) 1.63

Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics (2003) 1.57

Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog (2011) 1.53

Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol (2005) 1.39

Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys (2004) 1.30

Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. PLoS Pathog (2012) 1.10

Mapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitry. PLoS Genet (2012) 1.07

The Candida albicans pescadillo homolog is required for normal hypha-to-yeast morphogenesis and yeast proliferation. Proc Natl Acad Sci U S A (2008) 1.04

Thermal control of microbial development and virulence: molecular mechanisms of microbial temperature sensing. MBio (2012) 1.03

Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. PLoS Genet (2013) 0.97

Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs. Nat Rev Microbiol (2012) 0.96

Hsp90 orchestrates transcriptional regulation by Hsf1 and cell wall remodelling by MAPK signalling during thermal adaptation in a pathogenic yeast. PLoS Pathog (2012) 0.95

Elucidating drug resistance in human fungal pathogens. Future Microbiol (2014) 0.90

Cdc28 provides a molecular link between Hsp90, morphogenesis, and cell cycle progression in Candida albicans. Mol Biol Cell (2011) 0.90

Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance. Cell Rep (2012) 0.90

The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance. PLoS One (2012) 0.89

A systems biology approach reveals the role of a novel methyltransferase in response to chemical stress and lipid homeostasis. PLoS Genet (2011) 0.84

Surviving the heat of the moment: a fungal pathogens perspective. PLoS Pathog (2013) 0.84

Uncovering cellular circuitry controlling temperature-dependent fungal morphogenesis. Virulence (2012) 0.82

Metabolic control of antifungal drug resistance. Fungal Genet Biol (2009) 0.81

Regulatory circuitry governing morphogenesis in Saccharomyces cerevisiae and Candida albicans. Cell Cycle (2012) 0.79

Hsp90-dependent regulatory circuitry controlling temperature-dependent fungal development and virulence. Cell Microbiol (2014) 0.79

Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies. Cell Mol Life Sci (2015) 0.77

A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae. Mol Biosyst (2012) 0.76